孟鲁司特联合沙美特罗替卡松气雾剂治疗咳嗽变异性哮喘患者的临床效果  

The Clinical Effect of the Combination of Shah Mette Lo Tikason and the Aerosol in the Treatment of Cough Variant Asthma

作　　者：崔跃[1] 

机构地区：[1]沈阳市第五人民医院,辽宁沈阳110023

出　　处：《中国药物经济学》2016年第1期44-45,共2页China Journal of Pharmaceutical Economics

摘　　要：目的探讨孟鲁司特联合沙美特罗替卡松气雾剂治疗咳嗽变异性哮喘(CVA)患者的临床效果。方法选取2014年1-12月沈阳市第五人民医院收治的84例CVA患者作为研究对象,按随机数字表法将其分为观察组和对照组,各42例。对照组患者吸入沙美特罗替卡松气雾剂,观察组患者在对照组基础上睡前顿服孟鲁司特,比较两组患者的临床治疗效果、症状改善情况、治疗后复发及不良反应发生情况。结果观察组患者治疗的总有效率明显高于对照组,差异有统计学意义(P<0.05);治疗后,观察组患者的日间症状评分、夜间症状评分均明显低于对照组,差异均有统计学意义(均P<0.05);观察组患者的复发率明显低于对照组,差异有统计学意义(P<0.05)。结论孟鲁司特联合沙美特罗替卡松气雾剂治疗CVA能明显缓解患者的临床症状,且复发率低,不良反应少。Objective To investigate the clinical effect of the combination of Shah Mette Lo Tikason and in the treatment of cough variant asthma.Methods From December 2014 to January 2014,84 patients with CVA were selected as the research object,and according to the random number table method,the patients were divided into observation group and control group,42 cases in each group.The control group was treated with Shah Mette Lo Tikason aerosol,and the observation group was treated with the control group.The clinical therapeutic effect,symptom improvement,recurrence and adverse reactions of the two groups were compared.Results The total effective rate in observation group was significantly higher than that in control group（P 〈0.05）;the daytime symptom score and night symptom score of observation group were significantly lower than those in control group（P 〈0.05）,the recurrence rate was significantly lower in observation group than in control group（P 〈0.05）.Conclusion Can relieve the clinical symptoms of patients with CVA,and the recurrence rate is low,and the adverse reactions are few.

关 键 词：孟鲁司特 沙美特罗替卡松气雾剂 咳嗽变异性哮喘 

分 类 号：R562.25[医药卫生—呼吸系统]